Dosing Schedule of 5-aza-2′deoxycytidine as a Hypomethylating Agent in Avy Mice.

被引:0
|
作者
Drown, M. K. [1 ]
Colwell, M.
Drown, C. G. [1 ]
Faulk, C. [1 ]
机构
[1] Univ Minnesota, St Paul, MN 55108 USA
关键词
D O I
暂无
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
P30
引用
收藏
页码:94 / 94
页数:1
相关论文
共 50 条
  • [21] Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia
    Momparler, RL
    Cote, S
    Eliopoulos, N
    LEUKEMIA, 1997, 11 (02) : 175 - 180
  • [22] Pharmacological approach for optimization of the dose schedule of 5-Aza-2’-deoxycytidine (Decitabine) for the therapy of leukemia
    RL Momparler
    S Côté
    N Eliopoulos
    Leukemia, 1997, 11 : 175 - 180
  • [23] 5-aza-2′-deoxycytidine induced myocardial regeneration
    Kao, RL
    Davis, J
    Ibrahim, E
    Zhu, Q
    Pennington, GE
    Ganote, CE
    CIRCULATION, 2003, 108 (17) : 399 - 399
  • [24] INDUCTION OF GENE AMPLIFICATION BY 5-AZA-2'-DEOXYCYTIDINE
    PERRY, ME
    ROLFE, M
    MCINTYRE, P
    COMMANE, M
    STARK, GR
    MUTATION RESEARCH, 1992, 276 (03): : 189 - 197
  • [25] Teratogenic effects of the demethylating agent 5-aza-2'-deoxycytidine in the Swiss Webster mouse
    Branch, S
    Francis, BM
    Brownie, CF
    Chernoff, N
    TOXICOLOGY, 1996, 112 (01) : 37 - 43
  • [26] Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2'-deoxycytidine
    Shichijo, S
    Yamada, A
    Sagawa, K
    Iwamoto, O
    Sakata, M
    Nagai, K
    Itoh, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (07): : 751 - 756
  • [27] 5-aza-2′-deoxycytidine, a DNA demethylating agent, inhibits metastatic melanoma invasiveness
    Etievant, Chantal
    Desjobert, Cecile
    Carrier, Arnaud
    Delmas, Audrey
    Tost, Jorg
    Favre, Gilles
    Riond, Joelle
    Arimondo, Paola
    CANCER RESEARCH, 2014, 74 (19)
  • [28] The in vivo induction of sister chromatid exchange by the demethylating agent 5-aza-2′-deoxycytidine
    Rodriguez-Reyes, R.
    Morales-Ramirez, P.
    MUTAGENESIS, 2011, 26 (04) : 551 - 554
  • [29] Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
    Issa, JPJ
    Garcia-Manero, G
    Giles, FJ
    Mannari, R
    Thomas, D
    Faderl, S
    Bayar, E
    Lyons, J
    Rosenfeld, CS
    Cortes, J
    Kantarjian, HM
    BLOOD, 2004, 103 (05) : 1635 - 1640
  • [30] The Demethylating Agent 5-Aza-2′-Deoxycytidine (5-AZA-CdR) Inhibits The Development of Preimplantation Mouse Embryos
    Yu Jian-Ning
    Li Shao-Hua
    Wang Dan-Qiu
    Wang Meng
    Lin Fen
    Liu Hong-Lin
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (02) : 228 - 237